Business Development and Strategy

  • 製薬(バイオテクノロジー)
  • 経営者


Tyler Zanini was previously employed at Helix, from November 2015 to November 2018. Over three years, he held multiple roles across Corporate Development, Strategy, and Business Development. In the Corporate Development function, Tyler was responsible for developing market landscape and competitive analysis for consumer genomics. At the end of 2016, he started the Business Development team at Helix, where his mandate was to establish partnerships with large health systems, clinical reference labs, consumer brands, and existing consumer genomics companies. He has worked with large clinical testing labs, academic medical centers, and research organizations. He joined Helix as employee number 15 - shortly after the company was formed with an initial raise of $100M from Illumina, Warburg Pincus, and Sutter Hill Ventures. Helix went on to have over 200 employees and raise a $200M Series B from existing investors, DFJ, and KCPB. Some of Helix's existing partners include Geisinger, Mayo Clinic, Mt. Sinai, and National Geographic. Prior to Helix, Tyler was in an investing role at HIG Capital, a middle market private equity, where he focused on healthcare.
His professional experiences include: healthcare, biotech, precision medicine, personalized medicine, genomics, genetics, clinical testing lab, consumer genomics, sequencing, personalized health, DNA.
He has specific expertise in: business development, operations, corporate development, industry landscape, strategy, partnerships, entrants into the market, sustainability of businesses.
He has recently used, evaluated, or purchased the following products: Existing players in consumer genomics market, reviewed clinical testing labs, understanding of health systems and academic medical centers leveraging genomics.





Passion for building new businesses in cutting edge technology. Background in technology investment banking and healthcare private equity. Moved to Helix to help shape the future of personal genomics as we build an app store for products and services based on your DNA. Currently doing Business Development and helping partners build genetic products that are actionable and insightful.